During the past decade, Medical Oncology Centre of Rosebank conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 17 clinical trials were completed, i.e. on average, 81% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Oncology Centre of Rosebank" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Oncology Centre of Rosebank" #1 collaborator was "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Medical Oncology Centre of Rosebank" are "Breast Cancer" (8 trials), "Lung Cancer" (3 trials), "Multiple Myeloma" (3 trials), "Triple Negative Breast Cancer" (3 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Medical Oncology Centre of Rosebank" in a lesser frequency.

Most popular intervention types in "Medical Oncology Centre of Rosebank" are "Drug" (36 trials), "Biological" (6 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (7 trials), "Carboplatin" (6 trials), "Placebo" (6 trials), "Gemcitabine" (4 trials) and "fluorouracil" (3 trials). Other intervention names were less common.

The vast majority of trials in "Medical Oncology Centre of Rosebank" are 31 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Oncology Centre of Rosebank". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Medical Oncology Centre of Rosebank, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Oncology Centre of Rosebank, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".